Biolife solutions to report fourth quarter and full year 2023 financial results and business update on february 29, 2024

Bothell, wash. , feb. 20, 2024 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("cgt") and broader biopharma markets, today announced the company's fourth quarter and full year 2023 financial results will be released after market close on thursday, february 29, 2024.
BLFS Ratings Summary
BLFS Quant Ranking